共 449 条
[1]
Thal LA(1999)Occurrence and epidemiology of resistance to virginiamycin and streptogramins J Antimicrob Chemother 43 171-6
[2]
Zervos MJ(1998)Streptogramins: an answer to antibiotic resistance in gram-positive bacteria Lancet 352 591-2
[3]
Leclercq R(1998)The streptogramin antibiotics: update on their mechanism of action Expert Opin Invest Drug 7 591-9
[4]
Courvalin P(1992)RP 59500: a proposed mechanism for its bactericidal activity J Antimicrob Chemother 30 9-14
[5]
Beyer D(1998)Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada Diagn Microbiol Infect Dis 31 437-51
[6]
Pepper K(1999)Quinupristin/dalfopristin antimicrobial activity and spectrum in North America: report from 1998 isolates in the global Smart study [abstract no. P168] J Antimicrob Chemother 44 77-92
[7]
Aumercier M(1999)Results from the European component of the global Smart program: activity of quinupristin/dalfopristin tested against gram-positive cocci [abstract no. P172] J Antimicrob Chemother 44 78-12
[8]
Bouhallab S(1999)Quinupristin/dalfopristin activity against Latin American (LA) Gram-positive cocci: results from the global SMART surveillance study [abstract no. P205] J Antimicrob Chemother 44 85-9
[9]
Capmau M-L(1997)Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests J Antimicrob Chemother 39 87-9
[10]
Jones RN(1999)Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant Gram-positive bacteria: the role of streptogramins and other newer compounds Diagn Microbiol Infect Dis 33 101-9